Jean‐Frédéric Colombel

Author

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Colombel, Jean-Frederic, Colombel, Jean-Fréderic, Colombel, Jean-Frédéric, Drew Helmus, E Zimmermann, Elena Ricart, Gearry, Richard B., Hamed Khalili, Herfarth, H.H, J -F Colombel

1.4K

Publications

94.5K

Citations

139

H-Index

196

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Inserm University of California San Diego Hôpital Claude Huriez Centre Hospitalier Universitaire de Lille

About

Jean‐Frédéric Colombel is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	71	156	30K
2	Public Health	13	13	1.2K
3	Health Sciences	5	5	265
4	Engineering	1	1	10
5	Natural Sciences	1	1	21

Jean‐Frédéric Colombel

400

Publications

67.2K

Citations

118

H-Index

Page 1

	Year	Citations
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein, The Lancet InflammationChronic Inflammatory DiseasesAnti-inflammatoryMaintenance InfliximabGastroenterology	2002	4.1K
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis Paul Rutgeerts, William J. Sandborn, Brian G. Feagan, New England Journal of Medicine	2005	3.8K
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch, New England Journal of Medicine	2010	3.1K
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands, New England Journal of Medicine	2013	2.8K
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease William J. Sandborn, Brian G. Feagan, Paul Rutgeerts, New England Journal of Medicine	2013	2.6K
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management Gert Van Assche, James O. Lindsay, Marc Lémann, Journal of Crohn s and Colitis RheumatologyAnti-tnf TherapyAdolescent IbdGastroenterologyDiagnosis	2010	1.5K
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis William J. Sandborn, Gert Van Assche, Walter Reinisch, Gastroenterology InflammationRheumatologyAutoimmune DiseaseModerate-to-severe Ulcerative ColitisImmunology	2011	1.2K
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial Julián Panés, Damián García‐Olmo, Gert Van Assche, The Lancet Regenerative MedicineInflammationComplex Perianal FistulasMedicineGastroenterology	2016	1K
CARD15/NOD2 Mutational Analysis and Genotype-Phenotype Correlation in 612 Patients with Inflammatory Bowel Disease Suzanne Lesage, Habib Zouali, Jean‐Pierre Cézard, The American Journal of Human Genetics InflammationAutoimmune DiseaseGeneticsImmunologyGenetic Epidemiology	2002	982
Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab William J. Sandborn, Paul Rutgeerts, Robert Enns, Annals of Internal Medicine	2007	955

Page 1